Tuesday, November 5, 2024
HomeTagsShionogi

Shionogi

Novo Holdings Portfolio Company F2G Enters Strategic Collaboration With Shionogi to Commercialise Its New Antifungal Agent Olorofim in Europe and Asia

Novo Holdings A/S, a leading international life sciences investor, announces that its portfolio company F2G Ltd. (F2G) has entered into a strategic collaboration with...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics